Defining the value of structural inhibition: Is low-dose etanercept inferior to the standard dose?

Eric M. Ruderman

doi:10.1093/rheumatology/kes263

Defining the value of structural inhibition: Is low-dose etanercept inferior to the standard dose?

Eric M. Ruderman^*

^*Corresponding author for this work

Medicine, Rheumatology Division

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Article number	kes263
Pages (from-to)	2118-2119
Number of pages	2
Journal	Rheumatology (United Kingdom)
Volume	51
Issue number	12
DOIs	https://doi.org/10.1093/rheumatology/kes263
State	Published - Dec 2012

ASJC Scopus subject areas

Pharmacology (medical)
Rheumatology

Access to Document

10.1093/rheumatology/kes263

Cite this

@article{0d09fc2d88b34724a05a3c50843f6da0,

title = "Defining the value of structural inhibition: Is low-dose etanercept inferior to the standard dose?",

author = "Ruderman, {Eric M.}",

year = "2012",

month = dec,

doi = "10.1093/rheumatology/kes263",

language = "English (US)",

volume = "51",

pages = "2118--2119",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Defining the value of structural inhibition

T2 - Is low-dose etanercept inferior to the standard dose?

AU - Ruderman, Eric M.

PY - 2012/12

Y1 - 2012/12

UR - http://www.scopus.com/inward/record.url?scp=84870383451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870383451&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kes263

DO - 10.1093/rheumatology/kes263

M3 - Editorial

C2 - 23024059

AN - SCOPUS:84870383451

SN - 1462-0324

VL - 51

SP - 2118

EP - 2119

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 12

M1 - kes263

ER -

Defining the value of structural inhibition: Is low-dose etanercept inferior to the standard dose?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this